Skip to content

Psilocybin modulates nucleus accumbens activity via astrocytic transcriptional regulation

Su Min Kang, Dae-Si Kang, Tae-Yong Choi, Sejin Jeong, A-Hyeon Lee, Yujeong Jeong, Minjin Oh, Eum Ji Kim, Jieun Lee, Ki Jung Kim, Changjoon Justin Lee, Na Young Lim, Tae Woong Na, Bong Hyo Lee, Jae‐sung Bae, Sujeong Park, Suchan Chang, Jeansok John Kim

Experimental & molecular medicine November 5, 2026 DOI: 10.1038/s12276-026-01872-3 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Preclinical animal study Peer reviewed
Population Animals (species not specified in the abstract); nucleus accumbens tissue and cells
Interventions Psilocybin Psilocin Psilocybin-like tryptamines
Measures Ex vivo whole-cell recordings, extracellular GABA levels, intracellular GABA levels, ChIP–qPCR, calcium imaging
Topics Psilocybin
Key points Psilocybin-like tryptamines increased NAc neuronal activity while reducing extracellular GABA, and modulating NAc GABA receptor signaling altered psilocybin-appropriate responding. Psilocin reduced tonic (but not miniature synaptic) GABA currents in medium spiny neurons and selectively lowered astrocytic, not neuronal, intracellular GABA. The authors propose a model in which psilocybin regulates mesolimbic inhibitory tone via astrocyte-associated NFATc4/ALDH5A1-dependent GABA homeostasis.

Abstract

Abstract Psilocybin is a serotonergic hallucinogen that acts primarily through 5-HT₂A receptor signaling, yet the mechanisms by which it regulates mesolimbic inhibitory tone remain poorly understood. Here we investigated how psilocybin and structurally related synthetic tryptamines modulate inhibitory signaling in the nucleus accumbens (NAc) and whether astrocyte-associated mechanisms contribute to this process. Psilocybin-like tryptamines that generalized to the psilocybin cue increased NAc neuronal activity while reducing extracellular GABA levels, identifying diminished NAc GABAergic tone as a neurochemical correlate of psilocybin-like behavioral responses. Consistent with this interpretation, local pharmacological modulation of NAc GABA receptor signaling altered psilocybin-appropriate responding. We next examined the cellular and molecular basis of this GABAergic regulation. Ex vivo whole-cell recordings revealed that psilocin, the active metabolite of psilocybin, reduced tonic GABA current in NAc medium spiny neurons without affecting miniature inhibitory postsynaptic currents, indicating preferential modulation of tonic rather than miniature synaptic inhibition. Cell-type-specific analyses further showed that psilocybin selectively reduced intracellular GABA levels in astrocytes, but not neurons. Psilocybin increased astrocytic NFATc4 and ALDH5A1 protein expression together with enhanced H3K27 acetylation, and ChIP–qPCR analysis showed increased NFATc4 occupancy at the Aldh5a1 promoter. Consistent with upstream serotonergic signaling, psilocin-induced calcium responses in astrocytes were attenuated by 5-HT₂A receptor antagonism. Together, these findings support a model in which psilocybin modulates mesolimbic inhibitory tone through astrocyte-associated regulation of NAc GABA homeostasis. Our findings further identify astrocytic NFATc4-associated transcriptional regulation as a mechanism linked to ALDH5A1 expression, astrocytic GABA homeostasis and tonic inhibitory regulation in the NAc.

Comparable studies

Other preclinical and animal studies on psilocybin, most cited first.

Citations in the library

Explore topics